Stem Cell Research
Competitive repopulation assay monitors stem cell progeny after transplantation
Published in Gene Therapy Weekly, March 3rd, 2005
"In multiunit cord blood transplantation, hematopoietic stem cells from each unrelated cord blood (UCB) unit competitively reconstitute the hematopoietic system in a recipient. To evaluate the fate of the progeny of each UCB unit and to determine the effects of graft-versus-graft reaction, we established a novel competitive repopulation assay using non-obese diabetic severe combined immunodeficient gamma chain (NOD/SCID/gammac(null)) mice in which human T lymphocytes develop from CD34+ cells," scientists writing in the journal Molecular Therapy report.
"CD34+ cells...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-03-03)
More Articles from Gene Therapy Weekly
- Anthrax Risk Factors
Host ARAP3 production makes cells vulnerable to anthrax toxin - Brain Cancer
The attenuated adenovirus ONYX-015 fights glioma proliferation - Cancer Therapy
Fusion transgene elicits a robust immunological response to tumor cells - Gene Transfer
Gene transduction corrects cells from patients with Wiskott-Aldrich syndrome - Genetic Engineering
Genetically modified cytolytic T cells recognize and kill glioblastoma - Acute Myeloid Leukemia
XPD genetic variation predicts treatment outcome and AML risk after chemotherapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
